OpGen, Inc.
(NASDAQ : OPGN)

( )
OPGN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.32%90.401.3%$812.42m
AMGNAmgen Inc.
-0.03%186.921.2%$635.34m
GILDGilead Sciences, Inc.
0.33%66.980.9%$508.19m
BIIBBiogen Inc.
0.65%335.161.3%$445.14m
ILMNIllumina, Inc.
-0.01%302.243.5%$320.02m
REGNRegeneron Pharmaceuticals, Inc.
0.45%422.512.6%$304.29m
VRTXVertex Pharmaceuticals Incorporated
0.52%187.841.9%$269.00m
ALXNAlexion Pharmaceuticals, Inc.
0.71%129.842.0%$236.61m
SRPTSarepta Therapeutics, Inc.
0.22%140.5715.4%$155.25m
AAgilent Technologies, Inc.
1.28%78.511.6%$145.08m
EXASExact Sciences Corporation
-2.27%83.6325.3%$129.45m
INCYIncyte Corporation
-0.40%83.742.5%$115.31m
ARRYArray BioPharma Inc.
0.30%23.178.2%$109.81m
EXELExelixis, Inc.
-0.52%21.246.4%$84.04m
NBIXNeurocrine Biosciences, Inc.
-1.89%79.365.1%$80.57m

Company Profile

OpGen, Inc. operates as a precision medicine company using molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.